Colonoscopy
Conditions
Interventions
Experimental group (Chuan Bei Qing group):Diet preparation 3 days before examination. Intestinal cleaning usually requires two bottles of Chuanbaiqing, which are taken twice in the evening of the day
Control group (Fujingqing group):Diet preparation 3 days before examination. Generally, 4 bags of Fujingqing were taken twice after dinner on the day before the examination and 4 hours before the exam
Sponsors
Peking Union Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years old, gender unlimited; 2. Subjects preparing for colonoscopy; 3. Persons with autonomous capacity; 4. Liver, kidney and heart function are normal within 3 months (urine routine, blood biochemistry, electrocardiogram, etc., are normal); 5. Those who agree to participate in this experiment and sign the informed consent: 6. Those who can participate in all tests until the completion of the test
Exclusion criteria
Exclusion criteria: 1. Gastrointestinal perforation, toxic colitis, toxic megacolon, severe intestinal obstruction or gastrointestinal stenosis, obstruction of gastric empting (e.g., gastric weakness, gastric retention), any of the previous gastrointestinal surgery history; 2. People who are allergic to the ingredients contained in the experimental drug and the control drug; 3. Laboratory results at baseline showed clinical electrolyte abnormalities (hypernatremia (serum Na > 145mmol/L), hyponatremia (serum Na 1.45mmol/L), hypokalemia (serum K 110bpm* Note: Two additional readings should be taken at least 5 minutes apart to confirm sinus tachycardia at 110bpm. ? sinus bradycardia 100 bpm)... ? interface escape waveform. Supraventricular tachycardia (>100 bpm). ? ventricular tachycardia (persistent, pleomorphic, or monomorphic). ? Atrial fibrillation with rapid ventricular response (heart rate >110bpm). ? Evidence of diploid, triploid, or multifocal ventricular premature beats. ? chamber puff ? ventricular fibrillation ? tip torsion ventricular tachycardia ?R-on-T phenomenon ? Wide QRS tachycardia (diagnosis unknown) ? electric alternations. ? ventricular autonomous rhythm - heart rate <100bpm ? MOBITZtype II second - or third-degree atrioventricular (AV) block ? atrioventricular separation ? double branch block ? three-branch block ? left bundle branch block 9. Patients with severe cardiac insufficiency (NYHA Grade III-IV); 10. Severe liver insufficiency (ALT, AST, TBil any item higher than 2 times the upper limit of normal); 11. Participants who were tested with drugs affecting gastrointestinal motility, such as motility promoting drugs (metoclopramide, domperidone, Itopride, Moxapride, cinibili, etc.), erythromycin antibiotics, purgative agents (phenolphthalein, senna, bisaxidine, Ma Ren Runchang pills, Buzhong Yiqi Decoction, Siwu decoction, etc., including diet tea) 3 days before admission; 12. Researchers believe it may interfere with participants participating in the study or assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal cleanliness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intestinal bubble evaluation;Intestinal polyp detection rate;Researcher satisfaction;Subject compliance; | — |
Countries
China
Contacts
Public ContactYang Aiming
Peking Union Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed